SIMILAR PATTERNS OF AMINO ACIDS FOR 4M7K_H_ACTH302
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1a14 | NC10 FV (HEAVYCHAIN) (Mus musculus) |
PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.32A | 4m7kH-1a14H:22.7 | 4m7kH-1a14H:74.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1eap | IGG2B-KAPPA 17E8 FAB(HEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 113 | None | 0.44A | 4m7kH-1eapB:21.6 | 4m7kH-1eapB:65.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1egj | ANTIBODY (HEAVYCHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.34A | 4m7kH-1egjH:27.7 | 4m7kH-1egjH:66.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ehl | ANTI-(6-4)PHOTOPRODUCTANTIBODY 64M-2 FAB(HEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.40A | 4m7kH-1ehlH:23.6 | 4m7kH-1ehlH:65.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1eo8 | ANTIBODY (HEAVYCHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.38A | 4m7kH-1eo8H:27.2 | 4m7kH-1eo8H:72.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1f4w | ANTIBODY S-20-4, FABFRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 106 | None | 0.35A | 4m7kH-1f4wH:19.5 | 4m7kH-1f4wH:55.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jhl | IGG1-KAPPA D11.15 FV(HEAVY CHAIN) (Mus musculus) |
PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 107 | None | 0.41A | 4m7kH-1jhlH:22.8 | 4m7kH-1jhlH:72.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jnh | MONOCLONALANTI-ESTRADIOL10G6D6 FAB HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 108 | None | 0.43A | 4m7kH-1jnhB:25.4 | 4m7kH-1jnhB:64.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kb5 | ANTIBODY DESIRE-1 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.36A | 4m7kH-1kb5H:27.0 | 4m7kH-1kb5H:66.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1lk3 | 9D7 HEAVY CHAIN (Rattusnorvegicus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 108 | None | 0.29A | 4m7kH-1lk3H:26.8 | 4m7kH-1lk3H:67.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1lmk | ANTI-PHOSPHATIDYLINOSITOL SPECIFICPHOSPHOLIPASE CDIABODY (Mus musculus) |
PF07686(V-set) | 4 | VAL A 2TYR A 27ARG A 98TYR A 111 | None | 0.40A | 4m7kH-1lmkA:22.6 | 4m7kH-1lmkA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1mfa | IGG1-LAMBDA SE155-4FAB (HEAVY CHAIN) (Mus musculus) |
PF07686(V-set) | 4 | VAL H 252TYR H 277ARG H 348TYR H 357 | None | 0.41A | 4m7kH-1mfaH:22.6 | 4m7kH-1mfaH:62.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n4x | IMMUNOGLOBULIN HEAVYCHAIN VARIABLEREGION (Mus musculus) |
PF07686(V-set) | 4 | VAL H 302TYR H 327ARG H 398TYR H 409 | None | 0.16A | 4m7kH-1n4xH:22.0 | 4m7kH-1n4xH:49.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n7m | GERMLINE METALCHELATASE CATALYTICANTIBODY, CHAIN L (Homo sapiens;Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 2TYR L 27ARG L 98TYR L 103 | None | 0.19A | 4m7kH-1n7mL:22.5 | 4m7kH-1n7mL:83.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ngq | N1G9 (IGG1-LAMBDA) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 109 | None | 0.33A | 4m7kH-1ngqH:22.5 | 4m7kH-1ngqH:69.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nqb | SINGLE-CHAINANTIBODY FRAGMENT (Mus musculus) |
PF07686(V-set) | 4 | VAL A 2TYR A 27ARG A 98TYR A 109 | None | 0.28A | 4m7kH-1nqbA:22.3 | 4m7kH-1nqbA:49.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pg7 | MURINE ANTIBODY 6A6FAB FRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL X 2TYR X 27ARG X 94TYR X 102 | None | 0.40A | 4m7kH-1pg7X:22.7 | 4m7kH-1pg7X:62.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q0y | FAB 9B1, HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.38A | 4m7kH-1q0yH:24.3 | 4m7kH-1q0yH:71.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1qfu | PROTEIN(IMMUNOGLOBULINIGG1-KAPPA ANTIBODY(HEAVY CHAIN)) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.41A | 4m7kH-1qfuH:25.9 | 4m7kH-1qfuH:64.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1rih | HEAVY CHAIN OFANTIBODY 14F7 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.17A | 4m7kH-1rihH:23.1 | 4m7kH-1rihH:62.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1rmf | IGG2A-KAPPA R6.5 FAB(HEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 108 | None | 0.36A | 4m7kH-1rmfH:20.0 | 4m7kH-1rmfH:64.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1rur | IMMUNOGLOBULIN 13G5,HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.23A | 4m7kH-1rurH:28.2 | 4m7kH-1rurH:68.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1svz | SINGLE-CHAIN FVFRAGMENT 1696 (Mus musculus) |
PF07686(V-set) | 4 | VAL A 129TYR A 154ARG A 225TYR A 236 | None | 0.38A | 4m7kH-1svzA:15.6 | 4m7kH-1svzA:22.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1sy6 | OKT3 FAB HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 108 | None | 0.38A | 4m7kH-1sy6H:27.7 | 4m7kH-1sy6H:67.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yed | IGG1 FAB FRAGMENT(D.2.4) (Mus musculus) |
no annotation | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.41A | 4m7kH-1yedH:26.8 | 4m7kH-1yedH:64.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yee | IGG2A FAB FRAGMENT(D2.5) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.35A | 4m7kH-1yeeH:26.3 | 4m7kH-1yeeH:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2g60 | ANTI-FLAG M2 FABHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.32A | 4m7kH-2g60H:27.7 | 4m7kH-2g60H:63.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ok0 | FAB ED10 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.40A | 4m7kH-2ok0H:21.8 | 4m7kH-2ok0H:64.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2op4 | MURINE ANTIBODY FABRS2-1G9 IGG1 HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.26A | 4m7kH-2op4H:22.9 | 4m7kH-2op4H:70.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2xqy | A13-D6.3 MONOCLONALANTIBODY (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL G 2TYR G 27ARG G 94TYR G 102 | None | 0.21A | 4m7kH-2xqyG:27.8 | 4m7kH-2xqyG:56.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zch | MONOCLONAL ANTIBODY8G8F5 FAB (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.30A | 4m7kH-2zchH:26.7 | 4m7kH-2zchH:64.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zjs | FAB56 (HEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 108 | None | 0.30A | 4m7kH-2zjsH:23.1 | 4m7kH-2zjsH:75.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bqu | 3H6 FAB HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL D 2TYR D 27ARG D 98TYR D 111 | NoneNoneSO4 D 225 (-3.0A)None | 0.31A | 4m7kH-3bquD:27.3 | 4m7kH-3bquD:62.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3cvh | 25-D1.16 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 1TYR H 26ARG H 97TYR H 109 | None | 0.25A | 4m7kH-3cvhH:22.2 | 4m7kH-3cvhH:68.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3eo9 | EFALIZUMAB FABFRAGMENT, HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 110 | None | 0.44A | 4m7kH-3eo9H:21.7 | 4m7kH-3eo9H:75.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h3b | ANTI-ERBB2 ANTIBODYCHA21 (Mus musculus) |
PF07686(V-set) | 4 | VAL C 136TYR C 161ARG C 232TYR C 243 | None | 0.34A | 4m7kH-3h3bC:15.1 | 4m7kH-3h3bC:63.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3hc4 | IMMUNOGLOBULIN IGG1FAB, HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 105 | None | 0.20A | 4m7kH-3hc4H:26.1 | 4m7kH-3hc4H:80.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3hns | CS-35 FAB HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 107 | None | 0.15A | 4m7kH-3hnsH:28.1 | 4m7kH-3hnsH:64.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3i75 | ANTIBODY LIGHT CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 114 | None | 0.44A | 4m7kH-3i75B:27.3 | 4m7kH-3i75B:64.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3iy0 | FAB 14, HEAVY DOMAIN (Mus musculus) |
PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 109 | None | 0.39A | 4m7kH-3iy0H:22.9 | 4m7kH-3iy0H:53.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3j93 | NEUTRALIZINGANTIBODY 22A12,HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 97TYR H 108 | None | 0.39A | 4m7kH-3j93H:16.6 | 4m7kH-3j93H:65.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mxw | 5E1 HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.33A | 4m7kH-3mxwH:30.0 | 4m7kH-3mxwH:81.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nn8 | ENGINEERED SCFV,HEAVY CHAIN (Mus musculus) |
PF07686(V-set) | 4 | VAL A 2TYR A 27ARG A 99TYR A 111 | None | 0.31A | 4m7kH-3nn8A:20.5 | 4m7kH-3nn8A:57.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nz8 | MOUSE ANTI V3ANTIBODY 7C8 FAB,HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL A 2TYR A 27ARG A 94TYR A 102 | None | 0.28A | 4m7kH-3nz8A:27.9 | 4m7kH-3nz8A:67.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3oz9 | FAB NC-1 IGG2A HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.35A | 4m7kH-3oz9H:27.8 | 4m7kH-3oz9H:75.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3qpq | C1068 HEAVY CHAIN (Homo sapiens;Mus musculus) |
no annotation | 4 | VAL H 2TYR H 27ARG H 98TYR H 108 | PCA H 1 ( 3.4A)NoneNoneNone | 0.25A | 4m7kH-3qpqH:23.4 | 4m7kH-3qpqH:80.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ria | MOUSE MONOCLONAL FABFRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL F 2TYR F 27ARG F 98TYR F 111 | None | 0.41A | 4m7kH-3riaF:23.2 | 4m7kH-3riaF:66.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3s35 | 6.64 FAB HEAVY CHAIN (Homo sapiens;Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 106 | None | 0.31A | 4m7kH-3s35H:23.5 | 4m7kH-3s35H:65.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3tt1 | MOUSE MONOCLONAL1GG2A FAB FRAGMENT,KAPPA LIGHT CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 110 | None | 0.28A | 4m7kH-3tt1H:26.1 | 4m7kH-3tt1H:67.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uji | FAB REGION OF THEHEAVY CHAIN OFANTI-HIV-1 V3MONOCLONAL ANTIBODY2558 (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.28A | 4m7kH-3ujiH:22.3 | 4m7kH-3ujiH:74.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ag4 | MONOCLONAL ANTIBODY3E3 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.29A | 4m7kH-4ag4H:26.9 | 4m7kH-4ag4H:69.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ala | FAB 2H12 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 106 | None | 0.28A | 4m7kH-4alaH:24.9 | 4m7kH-4alaH:66.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bz1 | FAB 3E31 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 106 | None | 0.19A | 4m7kH-4bz1H:26.9 | 4m7kH-4bz1H:69.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cmh | HEAVY CHAIN OFSAR650984-FABFRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 109 | None | 0.18A | 4m7kH-4cmhB:26.1 | 4m7kH-4cmhB:82.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4f33 | MORAB-009 FAB HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 108 | PCA B 1 ( 3.3A)NoneNoneNone | 0.21A | 4m7kH-4f33B:30.4 | 4m7kH-4f33B:81.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h20 | HEAVY CHAIN OF FABFRAGMENT FROM THE ANTI-RICINMONOCLONAL ANTIBODYRAC18 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 108 | None | 0.34A | 4m7kH-4h20H:15.7 | 4m7kH-4h20H:66.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hwe | FAB HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 3TYR H 28ARG H 99TYR H 108 | None | 0.28A | 4m7kH-4hweH:22.0 | 4m7kH-4hweH:77.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4kuz | ANTIBODY 4A5 HEAVYCHAIN (Homo sapiens;Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 109 | None | 0.38A | 4m7kH-4kuzH:29.2 | 4m7kH-4kuzH:83.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4m43 | FRAGMENTANTIGEN-BINDING523-11 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.24A | 4m7kH-4m43H:22.5 | 4m7kH-4m43H:68.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mxv | ANTI-LYMPHOTOXINALPHA ANTIBODY HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL F 2TYR F 27ARG F 94TYR F 102 | None | 0.37A | 4m7kH-4mxvF:28.0 | 4m7kH-4mxvF:74.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4n8c | HEAVY CHAIN OFMONOCLONAL ANTIBODY (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 108 | None | 0.36A | 4m7kH-4n8cH:23.0 | 4m7kH-4n8cH:63.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nm4 | ANTIBODY CR8043,HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.22A | 4m7kH-4nm4H:21.9 | 4m7kH-4nm4H:76.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4pb9 | AB64 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.43A | 4m7kH-4pb9H:26.8 | 4m7kH-4pb9H:64.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4q6i | HEAVY CHAIN OFMURINE 2D5 FAB (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 94TYR B 102 | None | 0.38A | 4m7kH-4q6iB:24.6 | 4m7kH-4q6iB:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r96 | LLAMA GLAMA FAB 48A2AGAINST HUMAN CMET HCHAIN (Lama glama) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 108 | None | 0.42A | 4m7kH-4r96B:27.8 | 4m7kH-4r96B:78.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4u6h | HEAVY CHAIN OFMURINE ANTI-VACCINIAL1 IGG2A ANTIBODYM12B9 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL A 2TYR A 27ARG A 98TYR A 108 | None | 0.28A | 4m7kH-4u6hA:27.2 | 4m7kH-4u6hA:66.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ut9 | BROADLY NEUTRALIZINGHUMAN ANTIBODY EDE1C10 (Homo sapiens) |
PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.42A | 4m7kH-4ut9H:21.5 | 4m7kH-4ut9H:40.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4x0k | FAB FRAGMENT HEAVYCHAIN (Homo sapiens) |
no annotation | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.30A | 4m7kH-4x0kH:22.4 | 4m7kH-4x0kH:75.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zso | ANTIBODY HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 110 | None | 0.21A | 4m7kH-4zsoB:23.5 | 4m7kH-4zsoB:68.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a3i | ANTI-HAEMAGGLUTININHA1 FAB HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL C 2TYR C 27ARG C 98TYR C 114 | None | 0.31A | 4m7kH-5a3iC:25.1 | 4m7kH-5a3iC:74.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5cma | ANTIBODY CH8H9 FABHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 107 | None | 0.31A | 4m7kH-5cmaB:29.2 | 4m7kH-5cmaB:86.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5d93 | HEAVY CHAIN OF FABFRAGMENT FROM AMOUSE QSOX1-SPECIFICANTIBODY (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL C 2TYR C 27ARG C 98TYR C 105 | None | 0.23A | 4m7kH-5d93C:25.9 | 4m7kH-5d93C:87.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dk3 | HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 109 | None | 0.40A | 4m7kH-5dk3B:23.4 | 4m7kH-5dk3B:39.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f9w | HEAVY CHAIN OFCH235-LINEAGEANTIBODY CH235 (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 94TYR B 102 | None | 0.43A | 4m7kH-5f9wB:23.0 | 4m7kH-5f9wB:76.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i0z | CATALYTIC DNAANTIBODY (Mus musculus) |
PF07686(V-set) | 4 | VAL A 24TYR A 49ARG A 120TYR A 131 | None | 0.24A | 4m7kH-5i0zA:23.6 | 4m7kH-5i0zA:69.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i73 | 8B6 ANTIBODY, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 21TYR B 46ARG B 117TYR B 127 | None | 0.26A | 4m7kH-5i73B:26.6 | 4m7kH-5i73B:65.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5iwl | 5F9 DIABODY (Homo sapiens) |
no annotation | 4 | VAL B 2TYR B 27ARG B 98TYR B 106 | PCA B 1 ( 3.3A)NoneNoneNone | 0.33A | 4m7kH-5iwlB:22.1 | 4m7kH-5iwlB:43.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jxa | VRC03 HEAVY CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.30A | 4m7kH-5jxaH:21.1 | 4m7kH-5jxaH:68.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jyl | SCFV TSP7 (Mus musculus) |
PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 108 | NoneNoneNone CL B 303 (-4.9A) | 0.30A | 4m7kH-5jylB:23.5 | 4m7kH-5jylB:47.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jym | ANTIBODY SCFV TSP11 (Mus musculus) |
PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 111 | None | 0.34A | 4m7kH-5jymB:22.2 | 4m7kH-5jymB:49.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5kn5 | EPIREGULIN ANTIBODYLY3016859 FAB HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL A 2TYR A 27ARG A 98TYR A 107 | SO4 A 301 (-3.9A)NoneNoneSO4 A 301 (-4.1A) | 0.22A | 4m7kH-5kn5A:22.7 | 4m7kH-5kn5A:77.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5kvd | ZV-2 ANTIBODY FABHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | PCA H 1 ( 3.3A)NoneNoneNone | 0.27A | 4m7kH-5kvdH:23.1 | 4m7kH-5kvdH:71.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5l7x | MOUSE ANTIBODY FABFRAGMENT, IGG1-KAPPAHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.31A | 4m7kH-5l7xH:26.1 | 4m7kH-5l7xH:65.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lwy | V REGION HEAVY CHAIN (Mus musculus) |
PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 107 | None | 0.28A | 4m7kH-5lwyH:23.1 | 4m7kH-5lwyH:69.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lx9 | SINGLE-CHAINVARIABLE FRAGMENT (Mus musculus) |
PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 107 | None | 0.29A | 4m7kH-5lx9H:22.8 | 4m7kH-5lx9H:41.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5myx | FAB C#24 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 2TYR B 27ARG B 98TYR B 104 | PCA B 1 ( 3.3A)NoneNoneNone | 0.20A | 4m7kH-5myxB:28.5 | 4m7kH-5myxB:63.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ngv | ANTI-HUMAN ACTRIIBMAB BYM338HEAVY-CHAIN (Homo sapiens) |
no annotation | 4 | VAL H 2TYR H 27ARG H 98TYR H 104 | PCA H 1 ( 3.4A)NoneNoneNone | 0.32A | 4m7kH-5ngvH:22.3 | 4m7kH-5ngvH:36.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nph | HEAVY CHAIN OF FABFRAGMENT DERIVEDFROMNON-NEUTRALIZINGANTIBODY DAO5 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL H 2TYR H 27ARG H 98TYR H 109 | None | 0.42A | 4m7kH-5nphH:22.9 | 4m7kH-5nphH:53.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nuz | EOD01 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL A 2TYR A 27ARG A 94TYR A 102 | None | 0.26A | 4m7kH-5nuzA:24.0 | 4m7kH-5nuzA:65.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w5x | 3C10 FAB' HEAVYCHAIN (Rattusnorvegicus) |
no annotation | 4 | VAL H 2TYR H 27ARG H 98TYR H 107 | PCA H 1 ( 3.3A)NoneNoneNone | 0.34A | 4m7kH-5w5xH:23.8 | 4m7kH-5w5xH:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ywf | 2H4 HEAVY CHAIN (Mus musculus) |
no annotation | 4 | VAL B 2TYR B 27ARG B 98TYR B 107 | None | 0.30A | 4m7kH-5ywfB:22.5 | 4m7kH-5ywfB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ani | COLTUXIMAB FAB HEAVYCHAIN (Homo sapiens) |
no annotation | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.26A | 4m7kH-6aniH:23.4 | 4m7kH-6aniH:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6aq7 | POM6 FAB HEAVY CHAIN (Mus musculus) |
no annotation | 4 | VAL H 1TYR H 26ARG H 97TYR H 104 | None | 0.21A | 4m7kH-6aq7H:27.7 | 4m7kH-6aq7H:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bb4 | MOUSE MONOCLONALANTIBODY C5.2 FABHEAVY CHAIN (Mus musculus) |
no annotation | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.31A | 4m7kH-6bb4H:27.2 | 4m7kH-6bb4H:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cuf | - (-) |
no annotation | 4 | VAL 8 2TYR 8 27ARG 8 94TYR 8 102 | None | 0.42A | 4m7kH-6cuf8:20.1 | 4m7kH-6cuf8:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6db7 | HUMAN MONOCLONALANTI-HIV-1 GP120 V3ANTIBODY 1334 FABHEAVY CHAIN (Homo sapiens) |
no annotation | 4 | VAL H 2TYR H 27ARG H 94TYR H 102 | None | 0.34A | 4m7kH-6db7H:28.0 | 4m7kH-6db7H:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6ehx | SCFV ABVANCE:INCREASING OURKNOWLEDGE OFANTIBODY STRUCTURALSPACE TO ENABLEFASTER AND BETTERDECISION MAKING INDRUG DISCOVERY (Homo sapiens) |
no annotation | 4 | VAL B 2TYR B 27ARG B 98TYR B 110 | None | 0.28A | 4m7kH-6ehxB:20.9 | 4m7kH-6ehxB:42.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6ehy | SCFV ANTIBODYFRAGMENT (Homo sapiens) |
no annotation | 4 | VAL A 2TYR A 27ARG A 98TYR A 110 | None | 0.28A | 4m7kH-6ehyA:21.4 | 4m7kH-6ehyA:42.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ffj | - (-) |
no annotation | 4 | VAL A 2TYR A 27ARG A 98TYR A 114 | None | 0.38A | 4m7kH-6ffjA:21.6 | 4m7kH-6ffjA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6h0e | - (-) |
no annotation | 4 | VAL H 2TYR H 27ARG H 98TYR H 110 | PCA H 1 ( 3.3A)NoneNoneNone | 0.23A | 4m7kH-6h0eH:22.1 | 4m7kH-6h0eH:undetectable |